This article is general information, not legal or compliance advice. Covered entities should consult their own advisors.
To count a specialty prescription written by an outside specialist as a 340B referral claim, an FQHC typically documents three kinds of evidence: proof the patient is yours, evidence of the referral relationship with the specialist, and the pharmacy claim matched to that patient and that prescriber.
(That grouping is NuvemRx's, drawn from HRSA’s patient definition guidance and from the documentation practices NACHC describes in its Action Guide on 340B Referral Management; the guide itself does not prescribe a fixed list.)
Under HRSA's guidance, the test is whether responsibility for the patient’s care stayed with you. The evidence is how you prove it, and your own policies and procedures define which forms of it you require.
Here is the part most guides skip: the evidence you need most is created in systems you don't own. The consult note sits in the specialist's EMR. The fill sits in the pharmacy's system. Your chart holds the referral, in whatever form your EMR records it. Documentation for referral capture is a retrieval problem before it is a filing problem, and that is why so many health centers that are eligible for these savings never collect them.
Because the 340B patient definition is built on the patient relationship, not on who wrote the script. Under HRSA's 1996 guidance (61 Fed. Reg. 55156), an individual is a "patient" of a covered entity (with the exception of State-operated or funded AIDS drug purchasing assistance programs) only if:
HRSA's patient definition guidance refers to referrals. When your provider refers a patient to a cardiologist and the cardiologist writes the prescription, the patient is still yours as long as responsibility for their care remained with you and you can show it.
Two cautions. First, the patient definition is under active litigation. A drug manufacturer sued HRSA in April 2026 (AbbVie Inc. v. Kennedy et al., No. 1:26-cv-01190, D.D.C., filed April 8, 2026) after HRSA denied its request to audit covered entities using a narrower reading of "patient" than HRSA's guidance. Document as though you will be asked.
Second, keep the two steps separate in your own thinking. Your provider writes, generates, or is aware of the referral; a patient who self-refers to a specialist your provider knows about may still be considered a patient, depending on the covered entity's policies and HRSA guidance. The specialist writes the prescription. Programs that collapse those into one step tend to look for the evidence in the wrong place.
NACHC's Action Guide on 340B Referral Management starts with your policies and procedures: define what counts as a referral relationship for your organization, then document it the same way every time. Working from that guidance and from what we see across the referral programs we support, NuvemRx groups the evidence a 340B policy typically calls for into three categories.
1. Proof the patient is yours. An encounter at a registered site inside your policy's window, showing the patient was active with you when the prescription was written. This lives in your EMR, and you already have it.
2. Evidence of the referral relationship. The record that binds your care to the specialist's. For some health centers this is the referral order in your EMR. For others it is the specialist's consult note coming back, which names the prescriber or a colleague, the specialty, and the treatment. Many programs accept either one; roughly half of the health centers on the NuReferrals network accept a consult note alone as valid referral evidence. Covered entities define which forms count in their own policies, and HRSA expects them to follow those policies and to comply with the 340B statute and HRSA guidance. The consult note lives in the specialist's system, and unless you share an EMR instance, it does not come back on its own.
3. The pharmacy claim. The fill record, matched to the patient and to the prescriber on the referral evidence, inside the timing windows your policy sets. This lives in the pharmacy's system. It reaches you through your TPA for most of your network; for some pharmacies, it is visible only through a referral capture partner.
NACHC's guide also asks that every attempt to retrieve a consult note be documented. A documented request that went unanswered is part of your compliance record.
An auditor pulls a claim and asks whether the records prove the patient was yours and the care was yours to oversee. The checks NuReferrals runs against the consult note are a useful standard for any program, and you can hold your own process to them:
Which of these your program requires, and how strictly, is set by your policies and procedures. Most programs do not require all five; many, for example, do not require the drug to appear on the note. HRSA expects covered entities to follow their written policies and procedures, and audits against the 340B statute and HRSA guidance. A claim that does not satisfy the checks your policy requires may present compliance risk, however eligible it looked on the claims feed.
Most leakage comes from claims that could not be identified, matched, or defended, and the breaks tend to show up in the same places:
Name and identifier mismatches. The pharmacy has the patient's name spelled one way, your EMR another. The claim never matches the encounter, and the eligible script is never surfaced for review.
Timing gaps. The last encounter falls just outside the window, or the prescription was written before the referral was documented. The claim is eligible on its face and indefensible on paper.
Scripts you cannot see. The specialist wrote the prescription in an EMR you have no access to. Nothing in your data says it exists, so nothing flags it.
Specialty pharmacy filtering. Some specialty pharmacies send a TPA only the claims where the prescriber is already on the covered entity's provider list. An outside specialist is, by definition, not on that list. The claim is filtered out before anyone can evaluate it unless the pharmacy is told to send patient-matched claims regardless of prescriber.
Consult notes in someone else's EMR. The record that proves the claim sits with a specialist who has no obligation to send it. Retrieving it means outreach by phone, fax, portal, or health information exchange, logged every time.
Every one of those breaks happens in the handoff between systems that were never built to talk to each other. That is the fragmentation that leaks eligible savings out of a health center's program, and it is the reason a standard proforma usually values referral capture at close to zero. If you measure the opportunity from your own providers, or even from a list of the specialists you know you refer to, it looks like nothing, because you cannot know every provider your patients see. Nothing about the transaction originates in your data, so a model built on your data cannot see it.
Enough to be worth the retrieval. Across the NuvemRx network, the average qualified referral claim returned $387 to the covered entity in the first quarter of 2026. Specialty medications carry most of that value. At Jane Pauley Community Health Center, an Indianapolis FQHC, 67% of the $2.1M in net 340B savings captured over 15 months came from specialty prescriptions.
The same case study shows what the documentation standard is for. After an internal audit review identified claims it could not find appropriate documentation for, Jane Pauley moved its referral capture to NuReferrals.
The Capture Gap is the distance between finding a 340B-eligible referral and getting paid for it. A referral flagged in a report becomes a dollar only when the claim is identified, the consult note is retrieved, your policy's checks are passed, and the fill is captured wherever the patient chose to fill it, at a national chain, an independent, a specialty pharmacy, or your own entity-owned pharmacy.
Some tools scan your EMR to find referral signals quickly, but the missing document is often not in your EMR. Closing the gap takes people who retrieve the consult note from the specialist's office, a review that applies your policy to each claim, and a network wide enough to see and capture the fill wherever it happens. That is the work NuReferrals does: it identifies and qualifies the referral, handling up to 85% of the process; the referral team retrieves the note and completes the documentation; and the claim is captured wherever it fills.
Two things. First, seeing the claim at all. For much of your network the claims data reaches you through your TPA, but a referral claim you cannot identify is a claim you cannot capture, and for some pharmacy channels the referral opportunity is visible only through a referral capture partner. Second, the work after the flag: requesting the consult note from an office that owes you nothing, running your policy's checks on every claim, and building the audit page behind it. A flag earns nothing. Capture is the work.
That work belongs with people who do it all day. Your team has a health center to run. The NuReferrals team works referral claims across a dedicated referral capture network, with more than 30 ways to configure the checks to a health center's own policies. The patterns repeat. The name variant that hid one claim has hidden a hundred others, and the specialist's office that never answers a fax usually has a records department that will.
Two tests for any service: what does it earn on a claim that was flagged and never captured, and what does it earn when a captured claim fails an audit? A service paid only on captured, documented savings earns nothing in either case. Jane Pauley's audit is what the second test looks like in practice.
Start with your policies and procedures. Decide what counts as evidence of care ownership for your patients and your providers, given how your referrals actually happen, write it down, and capture against it the same way across your entire program. Then pull a sample of referral claims from the last 90 days and run each one through the checks your policy requires. Note where the chain broke. If the break is in your own EMR (missing encounters, undocumented referrals), that is a policy and training fix, or a partner whose process still catches the claim when a consult note exists and a referral order does not. If the break is in retrieval (consult notes you never received, specialty fills you never saw), that is an infrastructure problem, and it will not fix itself with more staff hours.
An assessment can tell you where the chain is broken. It cannot retrieve a consult note, and it may end when the report does. Ask anyone offering help who does the retrieval every month, and who supports the documentation after the engagement ends.
Then connect the result to what it funds. A health center that documents its referral claims well pays for the pharmacist, the Saturday clinic, or the insulin program that those specialty prescriptions were always eligible to fund. Getting the documentation right is how a pharmacy program becomes a Clinically Integrated Pharmacy: care that follows the patient to the specialist and back, with the savings returning to the community that generated them.
Want to know where your referral documentation chain is breaking? Let’s look at a sample of your claims together.
Can an FQHC claim 340B savings on a prescription written by an outside specialist?
Potentially, if the patient is the health center's patient, the referral relationship is documented, and the health center can show it retained responsibility for the patient's care, consistent with HRSA's patient definition guidance. Eligibility rests on the patient relationship, not on who wrote the prescription.
What documentation supports 340B eligibility for a referral prescription?
Three kinds of evidence: proof the patient is yours (an encounter inside your policy's window), evidence of the referral relationship (a referral order in your EMR, the specialist's consult note, or both, as your policy defines), and the pharmacy claim matched to the patient and prescriber. NACHC's Action Guide also calls for documenting every attempt to retrieve a consult note.
Does a referral order have to be in our EMR?
Only if your policy requires one. Many health centers accept the specialist's consult note as evidence of the referral relationship, with or without a written order, and some patients self-refer to a specialist your provider is aware of. Your policies and procedures decide; HRSA expects covered entities to follow their written policies and to comply with the 340B statute and HRSA guidance.
What are the most common reasons a referral claim fails audit review?
Patient identifiers that do not match across the consult note, claim, and encounter; a note or encounter outside the policy's timing window; a prescriber who cannot be tied to the note; and a missing consult note with no documented retrieval attempt.
Is referral capture compliant?
Referrals are named in HRSA's patient definition, so referral prescriptions may be eligible for 340B when the covered entity meets the patient definition. Compliance depends on documentation. The covered entity remains responsible for every claim, whoever processes it.
What does a 340B referral capture fee pay for?
Identifying referral claims you could not otherwise see, retrieving the specialist's consult note, applying your policy's checks to each claim, and building the audit record. Services paid on captured savings earn nothing on claims that are flagged but never captured.
How is referral capture different from standard 340B claim capture?
Standard capture matches claims, at contract pharmacies or your own entity-owned pharmacy, to prescriptions your own providers wrote. Referral capture matches claims for your patients written by providers who are not yours, filled at any of those same pharmacies. The matching logic is inferential rather than exact, and the supporting evidence originates outside your record.
Not yet a client? Start a conversation with us below.
Bookmark this link for continually updated resources and insights to help pharmacy become the engine that drives expanded care for your community.
This article is general information for 340B covered entities and is not legal, tax, accounting, or compliance advice. HRSA's patient definition guidance is the subject of pending litigation as of November 2026 and may change. Documentation requirements depend on each covered entity's own policies and procedures. The $387 figure is the average net savings per qualified referral claim (NuvemRx's advanced referral claim series) across the NuvemRx network in Q1 2026 and varies by payer mix, drug mix, and pharmacy network. Jane Pauley Community Health Center results describe one FQHC's program over 15 months (January 2025 through March 2026) and are specific to that organization. "Roughly half" of health centers accepting a consult note alone, and "more than 30 ways to configure" the checks, are NuvemRx internal estimates as of November 6, 2026. "Up to 85%" describes the share of the referral process NuReferrals automates; the remainder is completed by NuvemRx staff. Consult your own advisors and confirm the requirements that apply to your organization.